drugset
drugset / Trial / NCT00691184

Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis

NCT00691184 ↗

Phase 1 Completed 56 enrolled NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study, the safety and pharmacokinetics of 10 % terbinafine hydrogen chloride (HCl) nail lacquer wre investigated by comparison with vehicle control and 1% terbinafine cream

Timeline

Start
2005-02
Primary completion
2005-06
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terbinafine Small molecule 1 % Topical
Comparator Terbinafine Small molecule 10 % Topical
Comparator Terbinafine Small molecule 250 mg Topical

Indications

tinea infection